The NYU Abu Dhabi study published in the American Journal of Human Genetics examined single-cell transcriptomics of immune cells drawn from 126 children in Burkina Faso. According to the university, Fulani children displayed monocyte cells that were less inflammatory than those of their Mossi counterparts, thereby limiting disease pathogenesis while their B cells proved more active and pro-inflammatory to bolster antibody responses. The analysis highlighted how genetic factors combined with lifestyle elements such as the Fulani’s livestock-based diet shape these protective immune profiles. Researchers from the Environmental Genomics Lab collaborated with partners in Burkina Faso to complete two years of fieldwork that enabled the comparison.
NYU Abu Dhabi figures show that the Fulani group has long been observed as less susceptible to severe malaria outcomes than the Mossi in the same region. The study reported that differences in initial immune activation help prevent excessive inflammation that can worsen symptoms in vulnerable populations. This inter-ethnic variation offers concrete data on how diversity influences disease resistance across African communities. The research team included undergraduates Jakub Jurkovic, Bana Alamad and Odmaa Bayaraa who contributed to the data processing and interpretation.
Youssef Idaghdour, who directed the work, stated in the university announcement that the project highlights the power of leveraging genetic and lifestyle diversity in Africa to uncover novel biological insights. He added that the findings underscore the importance of empowering underserved populations in genomic studies to advance global health knowledge. The NYU Abu Dhabi study uncovers new path toward fighting Malaria through these targeted immune mechanisms that could inspire future interventions.
World Health Organization data from the World Malaria Report 2025 recorded an estimated 282 million malaria cases and 610,000 deaths worldwide in 2024. The WHO assessment found that the African Region accounted for 95 percent of both cases and fatalities, with 11 countries including Burkina Faso responsible for roughly two-thirds of the global total. Children under five years old represented the majority of deaths in the region according to the same WHO statistics. The NYU Abu Dhabi results arrive as efforts continue to address this persistent burden through improved understanding of natural immunity.
The American Journal of Human Genetics publication detailed how monocyte restraint in Fulani subjects protects host tissues while enhanced B cell function accelerates parasite clearance. According to the researchers, these balanced responses stem from both inherited traits and environmental influences tied to traditional herding practices. Such insights could inform the design of therapies that replicate protective elements in broader populations at risk. The study emphasized that African genetic diversity remains underrepresented in international research despite its potential to yield critical breakthroughs.
Collaborators in Burkina Faso facilitated ethical sample collection and local context for the NYU Abu Dhabi project, university officials reported. Earlier work from the same lab had compared metabolic responses to malaria across populations, laying groundwork for the current transcriptomic approach. The latest effort demonstrates how single-cell technologies can pinpoint actionable differences that laboratory models alone might miss. Ongoing analysis aims to validate these pathways for potential clinical translation in coming years.
